West Pharmaceutical Services
(NYSE) WST
West Pharmaceutical Services Financials at a Glance
Market Cap
$23.77B
Revenue (TTM)
$3.22B
Net Income (TTM)
$542.70M
EPS (TTM)
$7.48
P/E Ratio
44.97
Dividend
$0.87
Beta (Volatility)
0.89 (Low)
Dividend
$0.87
Beta (Volatility)
0.89 (Low)
Price
$342.79
Volume
317,809.644
Open
$335.72
Price
$342.79
Volume
317,809.644
Open
$335.72
Previous Close
$336.39
Daily Range
$335.72 - $345.99
52-Week Range
$206.80 - $345.99
Estimated Earnings Date
Jul 23, 2026
Dividend
$0.87
Beta (Volatility)
0.89 (Low)
Price
$342.79
Volume
317,809.644
Open
$335.72
Previous Close
$336.39
Daily Range
$335.72 - $345.99
52-Week Range
$206.80 - $345.99
Estimated Earnings Date
Jul 23, 2026
WST News
WST: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout West Pharmaceutical Services
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
10,800
CEO
Eric Mark Green, MBA
Website
www.westpharma.comHeadquarters
Exton, PA 19341-0645, US
WST Financials
Key Financial Metrics (TTM)
Gross Margin
36.24%
Operating Margin
20.67%
Net Income Margin
16.85%
Return on Equity
17.87%
Return on Capital
17.18%
Return on Assets
13.21%
Earnings Yield
2.22%
Dividend Yield
0.26%
Payout Ratio
11.39%
Stock Overview
Market Cap
$23.77B
Shares Outstanding
70.65M
Volume
317.81K
Avg. Volume
841.95K
Financials (TTM)
Gross Profit
$1.17B
Operating Income
$665.60M
EBITDA
$843.60M
Operating Cash Flow
$715.30M
Capital Expenditure
-$257.30M
Free Cash Flow
$458.00M
Cash & ST Invst.
$521.40M
Total Debt
$316.20M
West Pharmaceutical Services Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$844.90M
+21.0%
Gross Profit
$296.40M
+27.4%
Gross Margin
35.08%
N/A
Market Cap
$23.77B
N/A
Market Cap/Employee
$2.24M
N/A
Employees
10,600
N/A
Net Income
$138.80M
+54.6%
EBITDA
$218.50M
+44.8%
Quarterly Fundamentals
Total Cash
$521.40M
+29.0%
Total Debt
$316.20M
+4.3%
Accounts Receivable
$685.60M
+26.1%
Inventory
$452.60M
+16.4%
Long Term Debt
$294.80M
+4.8%
Short Term Debt
$21.40M
-1.8%
Return on Assets
13.21%
N/A
Return on Invested Capital
19.37%
N/A
Free Cash Flow
$47.20M
-18.8%
Operating Cash Flow
$89.90M
-30.5%